J. Marks-Konczalik
发表
T. Waldmann,
H. Sabzevari,
Y. Tagaya,
2000,
Proceedings of the National Academy of Sciences of the United States of America.
J. Moss,
S. Chu,
J. Marks-Konczalik,
1998,
Biochemical and biophysical research communications.
S. Birring,
L. Mcgarvey,
J. Smith,
2019,
What’s new? Clinical trials in lung disease.
J. Smith,
L. Mcgarvey,
I. Satia,
2017,
International journal of clinical pharmacology and therapeutics.
J. Moss,
A. Kristof,
J. Marks-Konczalik,
2001,
The Journal of Biological Chemistry.
S. Erzurum,
J. Moss,
S. Comhair,
2003,
American journal of physiology. Lung cellular and molecular physiology.
Shuying Yang,
S. Pascoe,
Elizabeth McKie,
2015,
Respiratory medicine.
David G. Behm,
S. Birring,
J. Smith,
2021,
ERJ Open Research.
K. Forsman-Semb,
J. Elborn,
K. Gunawardena,
2012,
European Respiratory Journal.
Biological effects of p38 MAPK inhibitor losmapimod does not translate to clinical benefits in COPD.
Shuying Yang,
S. Pascoe,
Elizabeth McKie,
2017,
Respiratory medicine.
M. Jaworska,
A. Gillissen,
B. Voß,
1998,
Lung.
Joel Moss,
S. Chu,
J. Marks-Konczalik,
1998,
The Journal of Biological Chemistry.
Joel Moss,
J. Moss,
A. Kristof,
2003,
Journal of Biological Chemistry.